10 20 30 40 50 60 70 80 1MTM - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER ISOMERASE(INTRAMOLECULAR OXIDOREDUCTASE)14-APR-95 1MTM
TITLE LOOP-1 MODELING OF MONOTIM-A100W MUTANT
COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRIOSEPHOSPHATE ISOMERASE; COMPND 3 CHAIN: A; COMPND 4 EC: 5.3.1.1; COMPND 5 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TRYPANOSOMA BRUCEI BRUCEI
KEYWDS ISOMERASE(INTRAMOLECULAR OXIDOREDUCTASE)
EXPDTA THEORETICAL MODEL
AUTHOR N.THANKI,R.ABAGYAN,R.WIERENGA
REVDAT 1 10-JUL-95 1MTM 0
JRNL AUTH T.V.BORCHERT,R.ABAGYAN,K.V.R.KISHAN,J.P.ZEELEN, JRNL AUTH 2 R.K.WIERENGA JRNL TITL THE CRYSTAL STRUCTURE OF AN ENGINEERED MONOMERIC JRNL TITL 2 TRIOSEPHOSPHATE ISOMERASE, MONOTIM: THE CORRECT JRNL TITL 3 MODELLING OF AN EIGHT-RESIDUE LOOP JRNL REF STRUCTURE (LONDON) V. 1 205 1993 JRNL REFN ASTM STRUE6 UK ISSN 0969-2126
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH R.A.ABAGYAN,M.M.TOTROV REMARK 1 TITL BIASED PROBABILITY MONTE CARLO CONFORMATIONAL REMARK 1 TITL 2 SEARCHES AND ELECTROSTATIC CALCULATIONS FOR REMARK 1 TITL 3 PEPTIDES AND PROTEINS REMARK 1 REF J.MOL.BIOL. V. 245 983 1994 REMARK 1 REFN ASTM JMOBAK UK ISSN 0022-2836
REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NULL REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1MTM COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998
REMARK 5 REMARK 5 LOOP-1 MODELING OF MONOTIM-A100W MUTANT: MONOTIM-A100W IS REMARK 5 A POINT MUTATION VARIANT OF MONOTIM. LOOP-1 IS MOBILE IN REMARK 5 THE CRYSTAL STRUCTURE. THE MODELING HAS BEEN AIMED AT REMARK 5 RIGIDIFYING THIS LOOP. RESIDUES 11 - 22 WERE KEPT UNFIXED REMARK 5 DURING THE MONTE CARLO RUN. REMARK 5 REMARK 5 RESIDUE NUMBER: 12 20 REMARK 5 WILD TYPE SEQUENCE: W K C N G S Q Q S L S E REMARK 5 MODELED SEQUENCE: W K * S G S P D S L S E REMARK 5 REMARK 5 ENERGY: -6526.1 KCAL/MOL (LOWEST ENERGY CONFORMATION; REMARK 5 ENERGIES OF OTHER FOUR LOW ENERGY CONFORMATIONS ARE: REMARK 5 -6522.0, -6517.7, -6515.9, -6513.1 KCAL/MOL) REMARK 5 USED ICM (RUBEN ABAGYAN, SKIRBALL INSTITUTE, NEW YORK) REMARK 5 FOR THE MODELING.
REMARK 220 REMARK 220 EXPERIMENTAL DETAILS REMARK 220 EXPERIMENT TYPE : THEORETICAL MODELLING REMARK 220 REMARK 220 REMARK: NULL
REMARK 225 REMARK 225 THEORETICAL MODEL REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE. REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE REMARK 225 RECORDS ARE MEANINGLESS.
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 CYS A 14 REMARK 465 ALA A 73 REMARK 465 PHE A 74 REMARK 465 THR A 75 REMARK 465 GLY A 76 REMARK 465 GLU A 77 REMARK 465 VAL A 78 REMARK 465 SER A 79
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 SER A 56 HIS A 57 -149.18 REMARK 500 LEU A 93 GLY A 94 145.22
REMARK 999 REMARK 999 CROSS REFERENCE TO SEQUENCE DATABASE REMARK 999 SWISS-PROT ENTRY NAME PDB ENTRY CHAIN NAME REMARK 999 TPIS_TRYBB REMARK 999 REMARK 999 SEQUENCE ADVISORY NOTICE REMARK 999 DIFFERENCE BETWEEN SWISS-PROT AND PDB SEQUENCE. REMARK 999 REMARK 999 SWISS-PROT ENTRY NAME: TPIS_TRYBB REMARK 999 REMARK 999 SWISS-PROT RESIDUE PDB SEQRES REMARK 999 REMARK 999 NAME NUMBER NAME CHAIN SEQ/INSERT CODE REMARK 999 ASN 15 SER 15 REMARK 999 GLN 18 PRO 18 REMARK 999 GLN 19 ASP 19 REMARK 999 ILE 68 GLY 68 REMARK 999 ALA 69 ASN 69 REMARK 999 LYS 70 ALA 70 REMARK 999 SER 71 ASP 71 REMARK 999 PRO 81 ALA 81 REMARK 999 ILE 82 SER 82 REMARK 999 ALA 100 TRP 100
DBREF 1MTM A 1 250 UNP P04789 TPIS_TRYBB 1 250
SEQADV 1MTM SER A 15 UNP P04789 ASN 15 CONFLICT SEQADV 1MTM PRO A 18 UNP P04789 GLN 18 CONFLICT SEQADV 1MTM ASP A 19 UNP P04789 GLN 19 CONFLICT SEQADV 1MTM GLY A 68 UNP P04789 ILE 68 CONFLICT SEQADV 1MTM ASN A 69 UNP P04789 ALA 69 CONFLICT SEQADV 1MTM ALA A 70 UNP P04789 LYS 70 CONFLICT SEQADV 1MTM ASP A 71 UNP P04789 SER 71 CONFLICT SEQADV 1MTM ALA A 81 UNP P04789 PRO 81 CONFLICT SEQADV 1MTM SER A 82 UNP P04789 ILE 82 CONFLICT SEQADV 1MTM TRP A 100 UNP P04789 ALA 100 CONFLICT
SEQRES 1 A 250 MET SER LYS PRO GLN PRO ILE ALA ALA ALA ASN TRP LYS SEQRES 2 A 250 CYS SER GLY SER PRO ASP SER LEU SER GLU LEU ILE ASP SEQRES 3 A 250 LEU PHE ASN SER THR SER ILE ASN HIS ASP VAL GLN CYS SEQRES 4 A 250 VAL VAL ALA SER THR PHE VAL HIS LEU ALA MET THR LYS SEQRES 5 A 250 GLU ARG LEU SER HIS PRO LYS PHE VAL ILE ALA ALA GLN SEQRES 6 A 250 ASN ALA GLY ASN ALA ASP GLY ALA PHE THR GLY GLU VAL SEQRES 7 A 250 SER LEU ALA SER LEU LYS ASP PHE GLY VAL ASN TRP ILE SEQRES 8 A 250 VAL LEU GLY HIS SER GLU ARG ARG TRP TYR TYR GLY GLU SEQRES 9 A 250 THR ASN GLU ILE VAL ALA ASP LYS VAL ALA ALA ALA VAL SEQRES 10 A 250 ALA SER GLY PHE MET VAL ILE ALA CYS ILE GLY GLU THR SEQRES 11 A 250 LEU GLN GLU ARG GLU SER GLY ARG THR ALA VAL VAL VAL SEQRES 12 A 250 LEU THR GLN ILE ALA ALA ILE ALA LYS LYS LEU LYS LYS SEQRES 13 A 250 ALA ASP TRP ALA LYS VAL VAL ILE ALA TYR GLU PRO VAL SEQRES 14 A 250 TRP ALA ILE GLY THR GLY LYS VAL ALA THR PRO GLN GLN SEQRES 15 A 250 ALA GLN GLU ALA HIS ALA LEU ILE ARG SER TRP VAL SER SEQRES 16 A 250 SER LYS ILE GLY ALA ASP VAL ALA GLY GLU LEU ARG ILE SEQRES 17 A 250 LEU TYR GLY GLY SER VAL ASN GLY LYS ASN ALA ARG THR SEQRES 18 A 250 LEU TYR GLN GLN ARG ASP VAL ASN GLY PHE LEU VAL GLY SEQRES 19 A 250 GLY ALA SER LEU LYS PRO GLU PHE VAL ASP ILE ILE LYS SEQRES 20 A 250 ALA THR GLN
FTNOTE 1 SER 56 - HIS 57 OMEGA = 210.82 PEPTIDE BOND DEVIATES FTNOTE 1 SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 2 LEU 93 - GLY 94 OMEGA = 145.22 PEPTIDE BOND DEVIATES FTNOTE 2 SIGNIFICANTLY FROM TRANS CONFORMATION
HELIX 1 1 PRO A 18 ASN A 29 1 12 HELIX 2 2 PHE A 45 ARG A 54 1 10 HELIX 3 3 ALA A 70 PHE A 86 1 10 HELIX 4 4 SER A 96 TRP A 100 1 5 HELIX 5 5 ASN A 106 SER A 119 1 14 HELIX 6 6 LEU A 131 SER A 136 1 6 HELIX 7 7 THR A 139 LYS A 153 1 15 HELIX 8 8 LYS A 156 ALA A 160 5 5 HELIX 9 9 VAL A 169 ALA A 171 5 3 HELIX 10 10 PRO A 180 LYS A 197 1 18 HELIX 11 11 ALA A 200 GLU A 205 1 6 HELIX 12 12 ALA A 219 TYR A 223 1 5 HELIX 13 13 GLY A 235 SER A 237 5 3 HELIX 14 14 PRO A 240 ALA A 248 5 9
SHEET 1 A 4 GLY A 230 VAL A 233 0 SHEET 2 A 4 PRO A 6 ASN A 11 1 N ILE A 7 O PHE A 231 SHEET 3 A 4 VAL A 37 ALA A 42 1 N GLN A 38 O PRO A 6 SHEET 4 A 4 PHE A 60 ALA A 63 1 N VAL A 61 O CYS A 39 SHEET 1 B 4 TRP A 90 LEU A 93 0 SHEET 2 B 4 MET A 122 ILE A 127 1 N MET A 122 O ILE A 91 SHEET 3 B 4 VAL A 162 GLU A 167 1 N VAL A 163 O VAL A 123 SHEET 4 B 4 ILE A 208 GLY A 211 1 N LEU A 209 O ILE A 164
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000